Reference summary — not medical advice or a personal risk estimate.
Hepatitis C virus (HCV)
Summary
Chronic infection with HCV is associated with liver cancer and non-Hodgkin lymphoma.
Detail
Chronic HCV infection is Group 1 with sufficient evidence for liver cancer and limited evidence for non-Hodgkin lymphoma. Transmitted via blood-to-blood exposure (shared needles, historical transfusions before blood-supply screening). WHO and international hepatitis programmes recommend at least one-time HCV testing in adults and treatment of those who test positive; clearing the infection substantially reduces subsequent liver cancer risk.
Regional relevance
global
Sources
Primary sources
Supporting sources
- ECDC — ECDC — Communicable diseases and cancer risk (European Centre for Disease Prevention and Control)
- Canadian Cancer Society — Canadian Cancer Society — Reduce your risk
- ACS — ACS — Known and Probable Human Carcinogens
- Cancer Research UK — Cancer Research UK — Causes of cancer and reducing your risk
- NTP — NTP — Report on Carcinogens (US National Toxicology Program)
Consumer references
Third-party tools some readers use alongside primary evidence. Meyron doesn't endorse them; we link them because you'll otherwise hit them anyway.
- California Prop 65 list
State of California's list of chemicals known to cause cancer or reproductive harm.